Speranza Therapeutics

Bridging the gap between hope and healing

Claim My Business
Security Type
Common Stock
Technology, Healthcare & Medical
Min Investment
Boca Raton, FL
Expected Close Date
August 01, 2022
Target Raise
No. Investors
Security Price
Number of Employees
Short Term Debt
Cost of Goods
Long Term Debt
Net Income

Company Description

Speranza Therapeutics is a medical device and biotech company that develops, distributes, and clinically supports medical devices and generic drugs that treat a variety of disease states and conditions. More than a company that supplies a drug or device to a patient or physician, we provide solutions as part of a medical protocol and we aim to produce positive outcomes for struggling patients in areas with unmet needs.


StartEngine OWNERS Exclusive Click here to learn more

$599+ Investment
StartEngine Owner’s Bonus
This offering is eligible for the StartEngine Owner’s 10% Bonus program. For details on this program, please see the Offering Summary section below.

Friends and Family Early Birds
Invest within the first week and receive 15% Bonus Shares





$5,000+ Investment
Tier 1
Invest $5,000+ , and receive 2% Bonus Shares

$15,000+ Investment
Tier 2
Invest $15,000+ , and receive 5% Bonus Shares

$30,000+ Investment
Tier 3
Invest $30,000+ , and receive 10% Bonus Shares

Key Deal Facts

We believe Speranza is addressing unmet needs - our newest device speaks directly to the OUD (opioid use disorder) market, with potential for expansion into other indications, such as acute pain management, Parkinson's disease, and PTSD

Developing an affordable over-the-counter (OTC) product aimed at the underserved oncology population receiving chemotherapy.

Experienced management team - The co-founders of Speranza have proven track records in healthcare and are experienced executives

Management Team / Advisory Board Bios

Joseph Bissonnette, CPA

Chief Financial Officer

Joseph C. Bissonnette’s extensive background covers 42 years in the accounting, tax and business consulting fields. For the first 15 years of his career, he focused on audit, controllerships and financial management positions in various industries prior. Mr. Bissonnette later founded his own firm and remains the sole owner of Joseph C. Bissonnette & Co. CPAs, and a partner at Audibert, Bissonnette & Co. CPAs. His specific expertise lies in the areas of financial analysis and business planning, tax and accounting issues, and management consulting. Mr. Bissonnette graduated from the University of Connecticut School of Business with a bachelor’s degree in accounting and taxation.
At Speranza Therapeutics, Mr. Bissonnette has been an integral part of the planning, startup, and implementation of accounting, tax and management systems to date. He is actively involved in the management and oversight of all financial planning and tax areas of the company. Mr Bissonnette works an average of 10 to 15 hrs per week on Speranza related issues and accounting, and 10 hrs per week at the accounting firm of Audibert,Bissonnette & Co. 

Scott Kalcic

Chief Technology Officer

Scott Kalcic has more than 25 years of information technology management and consulting experience with extensive knowledge in IT operations management, systems implementation, security, and regulatory compliance. Mr. Kalcic studied Business Management and Info Systems Programming at Purdue University and started his professional career at Price Waterhouse (PW) where he worked in internal accounting. While at PW he had the opportunity to assist in the management of their departmental network server system. This fueled his enthusiasm to become a certified network engineer and led to a successful career as a senior-level information technology executive.
Mr. Kalcic’s career accomplishments include a lead network consulting role in the migration of data at Caremark after their acquisition of a mail-order pharmacy in Culver City, CA, divisional management of an electronic software deployment group at Ernst & Young that included the western third of the US and more than 35 locations in 17 states, operational management for a full data center build and staff reorganization at Gibson Dunn & Crutcher LLP, senior project advisory and staff provisioning for a 40+ location multinational IT rollout that consisted of the entire network (ISP, Infrastructure, Desktop, Staffing) for Rotadyne, and senior project management for the deployment of a claims processing system at West Virginia Mutual Insurance. Mr. Kalcic also owns an IT consulting firm that specializes in managed services and security consulting. Prior to joining Speranza, he held a leadership role for a PCI audit engagement at Marriott Vacations Worldwide in Orlando, Fl.
Mr. Kalcic joined Mr. Rafanelli, Mr. Carrico, and Mr. Krasinsky at BiologicTx® in the companies’ earliest stages. He managed overall information technology operations. He successfully led the implementation of a full series of HIPAA compliant systems and technical policies as well as assisted in obtaining URAC compliance. BiologicTx merged with a company called Matrix to create BioMatrix, which was bought by a private equity company. He held an integral role in the combination of information technology systems and policies post-merger.
At Speranza Therapeutics, Mr. Kalcic is our Chief Technology Officer based out of Illinois where he lives with his wife and two children. He is motivated by his desire to leverage best-of-class technology solutions to ensure ongoing improvement in the patient’s treatment experience.

Vaughn Bell, MDiv

Senior Vice President, Growth Strategy

Vaughn Bell, MDiv has been dedicated to the addiction and mental health industry for all of her 35 years in the behavioral health industry. Following her graduation from Samford University with a degree in Psychology she completed her Masters of Divinity in Pastoral Counseling from Southern Baptist Theological Seminary. While working on her Master’s degree, Ms. Bell worked in inpatient treatment settings with Adolescent substance abuse patients and found her passion helping others find help from addiction, trauma and mental health issues. After receiving certifications in alcohol and drug counseling and marriage and family therapy Ms. Bell worked in a number of psychiatric hospitals within the National Medical Enterprise and Charter Behavioral Health System working directly with clients in counseling and ultimately overseeing the hospital admissions functions, outpatient services, and ultimately marketing and business development. She spent the next 10 years overseeing marketing in sales over multiple hospitals across the country, growing to an oversight of 25 facilities while at Charter Behavioral health across the southeast and Midwest.
As her career expanded over the next 20 years, Ms. Bell has overseen the marketing and business development functions at multiple companies including Behavioral healthcare corporation, Springstone, Elements Behavioral health, Odyssey Behavioral Health, Landmark Recovery and Pinnacle Treatment Centers. Her national footprint across the country gives her an extensive network and knowledge of the Treatment field and she is well versed in census management and has led multiple sales teams to achieve and surpass census and EBIDTA goals year after year while assuring clinically sound care is delivered to all patients.
Ms. Bell’s healthcare experience also encompasses several years in the health insurance industry working in Operations as the Account Service Director at Humana, as well as a stint as the Chief Marketing Officer of InnovaTel Telepsychiatry. Ms. Bell’s broad experience across the healthcare spectrum makes her uniquely qualified to lead business development and sales efforts in her role as SVP of Growth Strategy with Speranza. Ms. Bell was immediately drawn to the innovative treatment approach afforded to opioid patients with the S.T.Genesis and is able to use her extensive clinical knowledge and national network to bring a new and exciting detox device to help relief the pain and suffering of those she has worked for 30 years to help find recovery. She brings a knowledge of both treatment and successful recovery to her passion for the patients and families we serve.

Melanie Rosenblatt, MD

Medical Advisor

Melanie Rosenblatt, MD is a graduate of SUNY at Stony Brook School of Medicine. She completed her anesthesia residency and pain training at St Joseph’s Hospital Health Center in Syracuse, NY. She is board certified in Anesthesiology, Pain Management and Addiction Medicine. She has been practicing in South Florida since 1995 and maintains her private practice in Boca Raton, FL. Melanie Rosenblatt was the Medical Director of Pain Management for Broward Health North, a level II trauma center from 2002 to 2017 where she was the chairperson of the Credentials and Qualifications Committee and sat on the Medical Executive Board. She is a founding partner of Melrose Pain Solutions and she is the Chief Medical Officer of iRecovery. 
She is a consultant for the DEA, FBI, and many hospital systems in evaluating opioid prescribing patterns. She serves as a medical expert in the national opioid litigation and has testified extensively about appropriate opioid prescribing and how doctors make prescribing decisions. Melanie Rosenblatt is a recognized thought leader and national expert in her field.
Amount Raised : $10,646
Reveal the Score by Voting
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
The value of the company compared to similar companies raising money from investors.

Security Description

Common stock is a security that represents ownership in a corporation.

Research Reports

No reports have been submitted

Become a Reporter